文献速递主动脉疾病

腹主动脉瘤中糖代谢的转化应用

Translational applications of glucose metabolism in abdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2019-05-27

本文总结血糖参数与腹主动脉瘤患者临床结局的关系,探讨葡萄糖靶向方法的转化应用及临床潜力。糖尿病虽为心血管事件主要风险,却与腹主动脉瘤负相关,理解该机制有助于发现预后和治疗靶点。

要点

  • 糖尿病与腹主动脉瘤呈负相关,机制探索可揭示预后与治疗靶点。
  • 血糖参数与腹主动脉瘤临床结局相关,需进一步明确。
  • 葡萄糖靶向方法具有转化应用潜力,值得临床关注。

核心结论

  • 理解糖尿病与腹主动脉瘤负相关的机制可带来新的预后和治疗靶点。

研究设计与样本

  • 本文为综述,总结血糖参数与腹主动脉瘤患者临床结局关系的现有知识。

主要发现

  • 糖尿病虽为心血管事件和动脉粥样硬化相关疾病的主要风险,但与腹主动脉瘤呈负相关。

临床怎么用

  • 葡萄糖靶向方法在腹主动脉瘤临床实践中具有潜在应用价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Even though diabetes mellitus is a major risk for cardiovascular events and atherosclerosis-related diseases, it is negatively associated with abdominal aortic aneurysm. The understanding of the mechanisms underlying this negative association could bring new insights to identify prognostic and therapeutic targets. Here we summarize current knowledge of the relationship between glycemic parameters and clinical outcomes of patients with abdominal aortic aneurysm. Translational applications of glucose-targeted approaches as well as their potential interest for clinical practice are discussed in this context.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lareyre F, Hassen-Khodja R, Raffort J, et al. Translational applications of glucose metabolism in abdominal aortic aneurysm. J Vasc Surg. 2019. PMID: 31147135. doi:10.1016/j.jvs.2019.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。